• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

热量均衡饮食变化与高心血管代谢风险个体的非酒精性脂肪肝

Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals.

机构信息

Department of Clinical Medicine and Surgery, Federico II University, 80131 Naples, Italy.

出版信息

Nutrients. 2017 Sep 26;9(10):1065. doi: 10.3390/nu9101065.

DOI:10.3390/nu9101065
PMID:28954437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5691682/
Abstract

Non-alcoholic fatty liver disease (NAFLD) incorporates an extensive spectrum of histologic liver abnormalities, varying from simple triglyceride accumulation in hepatocytes non-alcoholic fatty liver (NAFL) to non-alcoholic steatohepatitis (NASH), and it is the most frequent chronic liver disease in the industrialized world. Beyond liver related complications such as cirrhosis and hepatocellular carcinoma, NAFLD is also an emerging risk factor for type 2 diabetes and cardiovascular disease. Currently, lifestyle intervention including strategies to reduce body weight and to increase regular physical activity represents the mainstay of NAFLD management. Total caloric intake plays a very important role in both the development and the treatment of NAFLD; however, apart from the caloric restriction alone, modifying the quality of the diet and modulating either the macro- or micronutrient composition can also markedly affect the clinical evolution of NAFLD, offering a more realistic and feasible treatment alternative. The aim of the present review is to summarize currently available evidence from randomized controlled trials on the effects of different nutrients including carbohydrates, lipids, protein and other dietary components, in isocaloric conditions, on NAFLD in people at high cardiometabolic risk. We also describe the plausible mechanisms by which different dietary components could modulate liver fat content.

摘要

非酒精性脂肪性肝病(NAFLD)包含广泛的组织学肝脏异常,从单纯的肝细胞内甘油三酯积聚(非酒精性脂肪肝,NAFL)到非酒精性脂肪性肝炎(NASH)不等,它是工业化世界最常见的慢性肝病。除了与肝脏相关的并发症,如肝硬化和肝细胞癌外,NAFLD也是 2 型糖尿病和心血管疾病的新兴危险因素。目前,生活方式干预包括减少体重和增加有规律的身体活动的策略,是 NAFLD 管理的主要方法。总热量摄入在 NAFLD 的发生和治疗中起着非常重要的作用;然而,除了单独的热量限制外,改变饮食的质量并调节宏量或微量营养素的组成也可以显著影响 NAFLD 的临床演变,提供更现实和可行的治疗选择。本综述的目的是总结目前在高心血管代谢风险人群中,等热量条件下,不同营养素(包括碳水化合物、脂肪、蛋白质和其他膳食成分)对 NAFLD 的随机对照试验的证据。我们还描述了不同的膳食成分如何通过可能的机制来调节肝内脂肪含量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9695/5691682/cf8f24442259/nutrients-09-01065-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9695/5691682/5bf0a3b1ced0/nutrients-09-01065-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9695/5691682/cf8f24442259/nutrients-09-01065-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9695/5691682/5bf0a3b1ced0/nutrients-09-01065-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9695/5691682/cf8f24442259/nutrients-09-01065-g002.jpg

相似文献

1
Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals.热量均衡饮食变化与高心血管代谢风险个体的非酒精性脂肪肝
Nutrients. 2017 Sep 26;9(10):1065. doi: 10.3390/nu9101065.
2
Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease.饮食组成与非酒精性脂肪性肝病管理中的体重减轻无关。
Nutrients. 2017 Jul 26;9(8):800. doi: 10.3390/nu9080800.
3
Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.非酒精性脂肪性肝病组织学谱中的心血管风险及临床表现:最新进展
World J Gastroenterol. 2015 Jun 14;21(22):6820-34. doi: 10.3748/wjg.v21.i22.6820.
4
Role of diet and nutritional management in non-alcoholic fatty liver disease.饮食和营养管理在非酒精性脂肪性肝病中的作用。
J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:81-7. doi: 10.1111/jgh.12244.
5
Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance.非酒精性脂肪性肝病和胰岛素抵抗的营养调节
Nutrients. 2015 Nov 5;7(11):9127-38. doi: 10.3390/nu7115454.
6
Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.非酒精性脂肪性肝病、代谢风险因素与肝细胞癌:一个悬而未决的问题。
World J Gastroenterol. 2015 Apr 14;21(14):4103-10. doi: 10.3748/wjg.v21.i14.4103.
7
Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetes.非酒精性脂肪性肝病和 2 型糖尿病患者的发病机制、筛查方式和治疗选择。
Diabet Med. 2020 Nov;37(11):1793-1806. doi: 10.1111/dme.14356. Epub 2020 Jul 13.
8
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?非酒精性脂肪性肝病与2型糖尿病:我们这个时代的肝脏疾病?
World J Gastroenterol. 2014 Jul 21;20(27):9072-89. doi: 10.3748/wjg.v20.i27.9072.
9
Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的流行病学与自然史
Semin Liver Dis. 2015 Aug;35(3):221-35. doi: 10.1055/s-0035-1562943. Epub 2015 Sep 17.
10
Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.非酒精性脂肪性肝病与肥胖:生化、代谢及临床表现
World J Gastroenterol. 2014 Jul 28;20(28):9330-7. doi: 10.3748/wjg.v20.i28.9330.

引用本文的文献

1
Impact of Helicobacter pylori Eradication on Clinical and Laboratory Parameters in Non-alcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials.幽门螺杆菌根除对非酒精性脂肪性肝病患者临床和实验室参数的影响:一项随机对照试验的系统评价和荟萃分析
Curr Med Sci. 2025 Feb;45(1):1-10. doi: 10.1007/s11596-025-00001-x. Epub 2025 Feb 25.
2
Practical Approaches to Managing Dyslipidemia in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.代谢功能障碍相关脂肪性肝病患者血脂异常管理的实用方法
J Lipid Atheroscler. 2025 Jan;14(1):5-29. doi: 10.12997/jla.2025.14.1.5. Epub 2024 Jun 26.
3

本文引用的文献

1
Mediterranean Diet and Prevention of Chronic Diseases.地中海饮食与慢性病预防
Nutr Today. 2017 Sep;52(5):208-222. doi: 10.1097/NT.0000000000000228. Epub 2017 Aug 15.
2
Systematic Review: Nutrition and Physical Activity in the Management of Paediatric Nonalcoholic Fatty Liver Disease.系统评价:营养与身体活动在儿童非酒精性脂肪性肝病管理中的作用
J Pediatr Gastroenterol Nutr. 2017 Aug;65(2):141-149. doi: 10.1097/MPG.0000000000001624.
3
A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease.一种针对非酒精性脂肪性肝病的营养基因组学方法。
Efficacy of the Mediterranean Diet Containing Different Macronutrients on Non-Alcoholic Fatty Liver Disease.
含不同宏量营养素的地中海饮食对非酒精性脂肪肝的疗效。
Nutrients. 2024 Aug 14;16(16):2699. doi: 10.3390/nu16162699.
4
Association between triglyceride-glucose index and risk of end-stage renal disease in patients with type 2 diabetes mellitus and chronic kidney disease.三酰甘油-葡萄糖指数与 2 型糖尿病合并慢性肾脏病患者发生终末期肾病风险的关系。
Front Endocrinol (Lausanne). 2023 Apr 20;14:1150980. doi: 10.3389/fendo.2023.1150980. eCollection 2023.
5
Waist Circumference as a Risk Factor for Non-Alcoholic Fatty Liver Disease in Older Adults in Guayaquil, Ecuador.厄瓜多尔瓜亚基尔市老年人腰围作为非酒精性脂肪性肝病的危险因素
Geriatrics (Basel). 2023 Apr 14;8(2):42. doi: 10.3390/geriatrics8020042.
6
Dietary intake and serum concentrations of vitamin A and vitamin E and pre-eclampsia risk in Chinese pregnant women: A matched case-control study.中国孕妇的饮食摄入、维生素A和维生素E血清浓度与先兆子痫风险:一项配对病例对照研究。
Front Nutr. 2023 Mar 30;10:1049055. doi: 10.3389/fnut.2023.1049055. eCollection 2023.
7
Association between Diet Quality and Index of Non-Alcoholic Steatohepatitis in a Large Population of People with Type 2 Diabetes: Data from the TOSCA.IT Study.2 型糖尿病患者大人群中饮食质量与非酒精性脂肪性肝炎指数的相关性:来自 TOSCA.IT 研究的数据。
Nutrients. 2022 Dec 15;14(24):5339. doi: 10.3390/nu14245339.
8
Obesity Management in the Primary Prevention of Hepatocellular Carcinoma.肝细胞癌一级预防中的肥胖管理
Cancers (Basel). 2022 Aug 22;14(16):4051. doi: 10.3390/cancers14164051.
9
Reduction of De Novo Lipogenesis Mediates Beneficial Effects of Isoenergetic Diets on Fatty Liver: Mechanistic Insights from the MEDEA Randomized Clinical Trial.从头合成脂肪生成的减少介导等能量饮食对脂肪肝的有益作用:来自 MEDEA 随机临床试验的机制见解。
Nutrients. 2022 May 23;14(10):2178. doi: 10.3390/nu14102178.
10
The consumption of micronutrients in relation to calorie intake and risk of insulin resistance.微量营养素的摄入量与卡路里摄入及胰岛素抵抗风险的关系。
Nutr Metab Cardiovasc Dis. 2022 Jun;32(6):1385-1391. doi: 10.1016/j.numecd.2022.02.007. Epub 2022 Feb 23.
Int J Mol Sci. 2017 Jul 16;18(7):1534. doi: 10.3390/ijms18071534.
4
Pediatric Non-Alcoholic Fatty Liver Disease.儿童非酒精性脂肪性肝病
Children (Basel). 2017 Jun 9;4(6):48. doi: 10.3390/children4060048.
5
Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity.腹部肥胖人群中果糖对心血管代谢风险因素和肝脂质代谢的不良影响。
J Intern Med. 2017 Aug;282(2):187-201. doi: 10.1111/joim.12632. Epub 2017 Jun 27.
6
Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments.非酒精性脂肪性肝病与胰岛素抵抗:新见解及潜在新疗法
Nutrients. 2017 Apr 14;9(4):387. doi: 10.3390/nu9040387.
7
Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO).成人中维生素D补充剂在预防和管理与矿物质稳态无关的主要慢性病中的应用:来自欧洲骨质疏松症与骨关节炎临床与经济学会(ESCEO)的证据研究及科学声明
Endocrine. 2017 May;56(2):245-261. doi: 10.1007/s12020-017-1290-9. Epub 2017 Apr 7.
8
The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms.地中海饮食模式作为非酒精性脂肪肝的首选饮食:证据和可能的机制。
Liver Int. 2017 Jul;37(7):936-949. doi: 10.1111/liv.13435. Epub 2017 Jun 1.
9
Effect of a Low Glycemic Index Mediterranean Diet on Non-Alcoholic Fatty Liver Disease. A Randomized Controlled Clinici Trial.低血糖指数地中海饮食对非酒精性脂肪性肝病的影响。一项随机对照临床试验。
J Nutr Health Aging. 2017;21(4):404-412. doi: 10.1007/s12603-016-0809-8.
10
Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet.非酒精性脂肪性肝病、肠道微生物群与饮食
Adv Nutr. 2017 Mar 15;8(2):240-252. doi: 10.3945/an.116.013151. Print 2017 Mar.